Functions to develop:

• Support in the definition of the business roadmap in innovation projects
• Support in the generation of spin-offs and the negotiation of transfers to third parties.
• Relationship with investors and other private financing agents.
• Foster public-private collaboration
• Attracting funding for the institution's strategic projects, especially in the international arena
• Development of the business model of the scientific and technological platforms.

Work placement:

Higher Degree

Requirements:

• University degree in life sciences: Biology, Biomedical Engineering, Pharmacy, Biochemistry, Medicine, etc
• Minimum 4 years of experience in the functions described.
• Minimum international experience of 3 years, in the last 10 years.
• MBA

We value:

• Curriculum vitae and suitability to the recommended profile.
• Knowledge of scientific project management, intellectual property and scientific communication.
• Technical knowledge in ICT or "medical device" technological developments.
• Knowledge of technology monitoring and assessment tools, market studies, business models and technology transfer.
• High level of communication-relational, organization and teamwork.
• Advanced level Catalan, Spanish and English (oral and written).

We offer:

The nominated candidates will be bound at work, through a contract of scientific and technical activities, of indefinite duration, in accordance with what is established in article 23-bis of Law 17/2022, of September 5 , which modifies Law 14/2011, of June 1, on Science, Technology and Innovation.

This place will be financed through the "Nodo de dinamización e innovación unicéntrico integrado Parc Taulí PT23/00005", financed by the Instituto de Salud Carlos III, and with possible financing by the Fondo Europeo de Desarrollo Regional (FEDER)"". of the Carlos III Health Institute, with co-financing by the European Union" and therefore its duration will be linked to it.

The dedication will be full-time and the working conditions in accordance with what is established in the current collective agreement applicable to the center

Selection process:

The general conditions of this call will be governed by what is included in this announcement and with the procedures detailed in the call for proposals for current positions, which can be consulted on the entity's website www.tauli.cat 

In accordance with the current Selection and Linking Code, candidates will undergo tests next:

• Curricular evaluation (merit evaluation in accordance with the items in the section will be evaluated and with the corresponding accreditations, except for the internal experience that will be accredited ex officio) included the letter of motivation accompanying the application.
• Personal interview (for professionals without internal experience) or managerial assessment.
• Psychotechnical test.

The competence tests that are considered necessary to assess the suitability of the can be added candidatures, within the framework of what is established in the current Selection and Linkage Code. In ares to the principles of procedural economy and speed of the process, the phases of the selection process can also be reduced in function of the ratio of candidates with compliance with the requirements of this offer.

In compliance with the LISMI, the Consortium will take into consideration the reservation for candidates that prove a disability equal to or greater than 33%, as long as they are suitable for development of the functions to be covered.

Documentation and registration:

Documentation:

The following documents in PDF format must be attached at the time of registration:

1.- Curriculum vitae.

2.- Qualification.

3.- Educational Accreditations

4.- Work experience (it will be necessary to accredit it through certificates of services provided in entities outside the center)

Link for registration: https://tauli.talentclue.com/ca/node/109020268 

Information:For inquiries in relation to this call, you can contact seleccio@tauli.cat indicating the reference number of this announcement.

Deadline:  July 15, 2024